FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904114429> ?p ?o ?g. }

• W2904114429 endingPage "218" @default.
• W2904114429 startingPage "214" @default.
• W2904114429 abstract "There is evidence that in the case of malignancies including lung cancer, that there is hypercoagulability. In spite of this, it is still not clear whether the course of chemotherapy alters the risk. This study aimed to investigate whether there was state of pre-thrombosis and hypercoagulability in patients with lung cancers and the underlying effect of chemotherapy during the treatment. Twelve lung cancer patients were recruited. Their stages and clinical performances were determined. The blood sample was taken before the chemotherapy, shortly after the first- and third-chemotherapy cycles, for the investigation of D-dimer, platelet count, PT (INR), ratios of APTT, and TT. The chemotherapy protocols vary from one patient to the others as well as between the 1st and the 3rd chemotherapy regimens although most of the protocols consist of carboplatin + gemcitabine or carboplatin + paclitaxel. From the thrombosis view of point, they were all asymptomatic and remained so during the period of investigation. Thrombosis is defined as an increase of D-dimer and hypercoagulability as finding one or more of PT (INR), ratio APTT, ratio TT <1.0. The trend of the result in the three sampling points was carried out by ANOVA, while Wilcoxon test for small samples did univariate analysis between two investigations. The result of PT, APTT, and TT indicating hypercoagulability showed that they remained unchanged until the third cycle of chemotherapy (p>0.05). The platelets of patients dropped significantly; median (range) 422 to 287 x 109/L before the chemotherapy to the end of the third cycle respectively. The D-Dimer of patients remained unchanged, however when it was investigated by univariate analysis in the group with D-Dimer >500 ng/mL, this group showed a decreased D-Dimer towards the end of the third cycle (p <0.05). This study demonstrated that there was hypercoagulability in patients with lung cancers before the chemotherapy until the 3rd cycle of chemotherapy. The course of chemotherapy did not alter hypercoagulability. However, in the group where pre-thrombosis had already happen as evidenced by high D-dimer (>500 ng/mL), the chemotherapy showed benefit regarding of reduction of the D-dimer which may lead to the possible breakdown of the existing thrombus." @default.
• W2904114429 created "2018-12-22" @default.
• W2904114429 creator A5019854613 @default.
• W2904114429 creator A5045563541 @default.
• W2904114429 creator A5069046817 @default.
• W2904114429 date "2018-07-01" @default.
• W2904114429 modified "2023-09-23" @default.
• W2904114429 title "HYPERCOAGULABILITY IN PATIENTS WITH LUNG CANCER UNDERGOING CHEMOTHERAPY" @default.
• W2904114429 doi "https://doi.org/10.24293/ijcpml.v24i3.1404" @default.
• W2904114429 hasPublicationYear "2018" @default.
• W2904114429 type Work @default.
• W2904114429 sameAs 2904114429 @default.
• W2904114429 citedByCount "0" @default.
• W2904114429 crossrefType "journal-article" @default.
• W2904114429 hasAuthorship W2904114429A5019854613 @default.
• W2904114429 hasAuthorship W2904114429A5045563541 @default.
• W2904114429 hasAuthorship W2904114429A5069046817 @default.
• W2904114429 hasBestOaLocation W29041144291 @default.
• W2904114429 hasConcept C121608353 @default.
• W2904114429 hasConcept C126322002 @default.
• W2904114429 hasConcept C141071460 @default.
• W2904114429 hasConcept C143998085 @default.
• W2904114429 hasConcept C2776256026 @default.
• W2904114429 hasConcept C2776694085 @default.
• W2904114429 hasConcept C2778239845 @default.
• W2904114429 hasConcept C2780868729 @default.
• W2904114429 hasConcept C2781451048 @default.
• W2904114429 hasConcept C71924100 @default.
• W2904114429 hasConcept C89560881 @default.
• W2904114429 hasConcept C90924648 @default.
• W2904114429 hasConceptScore W2904114429C121608353 @default.
• W2904114429 hasConceptScore W2904114429C126322002 @default.
• W2904114429 hasConceptScore W2904114429C141071460 @default.
• W2904114429 hasConceptScore W2904114429C143998085 @default.
• W2904114429 hasConceptScore W2904114429C2776256026 @default.
• W2904114429 hasConceptScore W2904114429C2776694085 @default.
• W2904114429 hasConceptScore W2904114429C2778239845 @default.
• W2904114429 hasConceptScore W2904114429C2780868729 @default.
• W2904114429 hasConceptScore W2904114429C2781451048 @default.
• W2904114429 hasConceptScore W2904114429C71924100 @default.
• W2904114429 hasConceptScore W2904114429C89560881 @default.
• W2904114429 hasConceptScore W2904114429C90924648 @default.
• W2904114429 hasIssue "3" @default.
• W2904114429 hasLocation W29041144291 @default.
• W2904114429 hasOpenAccess W2904114429 @default.
• W2904114429 hasPrimaryLocation W29041144291 @default.
• W2904114429 hasRelatedWork W1983784941 @default.
• W2904114429 hasRelatedWork W2000174546 @default.
• W2904114429 hasRelatedWork W2009022317 @default.
• W2904114429 hasRelatedWork W2053778437 @default.
• W2904114429 hasRelatedWork W2066950280 @default.
• W2904114429 hasRelatedWork W2072767112 @default.
• W2904114429 hasRelatedWork W2076107896 @default.
• W2904114429 hasRelatedWork W2105623825 @default.
• W2904114429 hasRelatedWork W2329182818 @default.
• W2904114429 hasRelatedWork W2413020017 @default.
• W2904114429 hasVolume "24" @default.
• W2904114429 isParatext "false" @default.
• W2904114429 isRetracted "false" @default.
• W2904114429 magId "2904114429" @default.
• W2904114429 workType "article" @default.